NEW PATIENT APPOINTMENT PATIENT REFERRAL

Clinical Trial

Trial Protocol ID USOR 24112_ TORL123-002

Trial Description

A Phase 2 Study Evaluating The Efficacy And Safety Of TORL-1-23 In Women With Advanced Platinum Resistant Epithelial Ovarian Cancer (Including Primary Peritoneal And Fallopian Tube Cancers) Expressing Claudin 6 (CLND6) (TORL123-002)

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Carol Tweed, MD

Disease Types

Sponsors

  • TORL Biotherapeutics, LLC
  • TRIO Clinical Research

ClinicalTrials.gov NCT ID

  • NCT06690775